Lumos Pharma, Inc. (LUMO) Financial Statements (2023 and earlier)

Company Profile

Business Address 4200 MARATHON BLVD.
AUSTIN, TX 78756
State of Incorp. DE
Fiscal Year End December 31
Industry (SIC) 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete Financial Analysis Financial Benchmarking

Balance Sheet (Statement of Financial Position) ($ in thousands)

6/30/2023
MRQ
12/31/2022
12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments, including:67,40094,80998,67990,549120,738158,708
Cash and cash equivalents56,00794,80998,67990,549120,738158,708
Short-term investments11,352     
Other undisclosed cash, cash equivalents, and short-term investments41     
Receivables22312826,26482479810,532
Other undisclosed current assets4,3864,7403,5063,0465,5366,226
Total current assets:72,00999,677128,44994,419127,072175,466
Noncurrent Assets
Operating lease, right-of-use asset230  735
Nontrade receivables     140140
Property, plant and equipment53793351,6333,7275,091
Other undisclosed noncurrent assets  556249   
Total noncurrent assets:2836355842,3683,8675,231
TOTAL ASSETS:72,292100,312129,03396,787130,939180,697
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities6,4754,7786,14210,6848,69421,723
Taxes payable  11  
Accounts payable2756122444755559,256
Accrued liabilities6,2004,1665,89810,1988,13912,467
Debt    4361160
Deferred rent credit     92
Liability for uncertainty in income taxes    653  
Deferred revenue and credits148
Other undisclosed current liabilities233352319447  
Total current liabilities:6,7085,1306,46111,8278,84722,031
Noncurrent Liabilities
Long-term debt and lease obligation, including:  205 8243111
Other undisclosed long-term debt and lease obligation     43111
Liabilities, other than long-term debt    906998
Deferred revenue and credits998
Deferred rent credit     906
Operating lease, liability 205 82
Other undisclosed noncurrent liabilities6,0005,7956,0006,0006,0006,000
Total noncurrent liabilities:6,0006,2056,0006,0826,9497,109
Total liabilities:12,70811,33512,46117,90915,79629,140
Equity
Equity, attributable to parent, including:59,58488,977116,57278,878115,143151,557
Treasury stock, value(170)(114) (1,454)(1,417)(1,142)
Additional paid in capital187,164185,429182,480413,959407,199389,786
Accumulated other comprehensive loss(9)     
Accumulated deficit(127,483)(96,421)(65,991)(334,001)(291,012)(237,459)
Other undisclosed equity, attributable to parent828383374373372
Total equity:59,58488,977116,57278,878115,143151,557
TOTAL LIABILITIES AND EQUITY:72,292100,312129,03396,787130,939180,697

Income Statement (P&L) ($ in thousands)

6/30/2023
TTM
12/31/2022
12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
Revenues1,52323016893612,47428,700
Revenue, net28,711
Gross profit:1,52323016893612,47428,700
Operating expenses(33,563)(31,577)(26,471)(46,070)(74,912)(101,592)
Other undisclosed operating income      11
Operating loss:(32,040)(31,347)(26,303)(45,134)(62,438)(72,881)
Nonoperating income9652816,6672,1571,875371
Investment income, nonoperating874122002,2262,029616
Other nonoperating income (expense)912696,467(19)(102)(126)
Interest and debt expense    (50)(52)(119)
Loss from continuing operations before equity method investments, income taxes:(31,075)(31,066)(19,636)(43,027)(60,615)(72,629)
Other undisclosed income from continuing operations before income taxes    5052119
Loss from continuing operations before income taxes:(31,075)(31,066)(19,636)(42,977)(60,563)(72,510)
Income tax expense (benefit)1363613,973(12)6,968559
Other undisclosed income from continuing operations      
Loss from continuing operations:(31,062)(30,430)(5,663)(42,989)(53,595)(71,951)
Loss before gain (loss) on sale of properties:(30,430)(5,663)(42,989)(53,595)(71,951)
Net loss attributable to parent:(31,062)(30,430)(5,663)(42,989)(53,595)(71,951)
Preferred stock dividends and other adjustments   (651)   
Net loss available to common stockholders, diluted:(31,062)(30,430)(6,314)(42,989)(53,595)(71,951)

Comprehensive Income ($ in thousands)

6/30/2023
TTM
12/31/2022
12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
Net loss:(31,062)(30,430)(5,663)(42,989)(53,595)(71,951)
Comprehensive loss:(31,062)(30,430)(5,663)(42,989)(53,595)(71,951)
Other undisclosed comprehensive loss, net of tax, attributable to parent(9)     
Comprehensive loss, net of tax, attributable to parent:(31,071)(30,430)(5,663)(42,989)(53,595)(71,951)

Statements Sources

The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: